This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
Solr Mobile Search
Page Title - Second Level
Publications and Digital Products
User account menu
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
Main page content
Advisory: Prescription Stimulant Misuse Among Youth and Young Adults
Publication ID
PEP21-06-01-003
Publication Date